On May 6, 2020, PharmaCyte Biotech announced it had received Medical Devices Establishment Registration with the FDAï¾’s Center…
On May 6, 2020, Humanigen announced that the first COVID-19 patient had been dosed in its previously announced…
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
On May 6, 2020, Predictive Oncology announced the acquisition of Soluble Therapeutics and partnership and licensing of a…
On May 6, 2020, Meridian Bioscience announced a collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for…
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
On May 5, 2020, the U.S. Dept. of Veterans Affairs (VA) announced the Airborne Hazards and Open Burn…
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
On May 5, 2020, Medigen Vaccine Biologics (MVB) announced a global commercial license agreement with National Institutes of…
On May 5, 2020, the HonorHealth Research Institute and HonorHealth announced the successful enrollment on a novel combination…
On May 6, 2020, Lineage Cell Therapeutics announced that it has applied for grant funding from the California…
On May 6, 2020, ResMed launched cloud-based remote monitoring software for ventilators and Lumis bilevel devices across Europe,…
On May 5, 2020, Organicell Regenerative Medicine announced the FDA has approved the Investigational New Drug application for…
On May 5, 2020, Tyson Foods announced resumption of limited production at its Waterloo, Iowa facility May 7….
On May 5, 2020, Innovation Pharma reported it had executed a Material Transfer Agreement (MTA) with a leading…
On May 5, 2020, Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham,…
On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
On May 5, 2020, Pfizer and BioNTech announced the first participants have been dosed in the U.S. in…
On May 5, 2020, Athersys announced the first patients have been enrolled in Athersysï¾’ pivotal Phase 2/3 study…
On May 5, 2020, Diffusion Pharmaceuticals announced the FDA accelerated its review of the Companyï¾’s clinical development plan…
On May 5, 2020, ACON Laboratories announced the availability of its SARS-COV-2 IgG/IgM Rapid Test. ACONï¾’s test is…
On May 4, 2020, a NIH study to help determine the rate of novel coronavirus infection in children…
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…
On May 4, 2020, Vir Biotech and Alnylam Pharma announced announced the selection of a development candidate for…
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
On May 4, 2020, Cerus announced FDA regulatory approval for manufacture of INTERCEPT plasma with a new, alternative…
On May 4, 2020, NanoViricides announced that it has signed a Confidential Disclosure Agreement with a leading pharmaceutical…
On May 4, 2020, Junshi Biosciences and Eli Lilly announced an agreement to co-develop therapeutic antibodies for the…